ArticleDrugs & therapy perspectives : for rational drug selection and use2019
Correction to: Osimertinib as first-line therapy in advanced NSCLC: a profile of its use.
Lesley J ScottPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleDrugs & therapy perspectives : for rational drug selection and use2019
Lesley J ScottPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.